Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness
NCT ID: NCT04498299
Last Updated: 2020-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2020-09-01
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to investigate changes after mild COVID-19 illness in echocardiographic indices at rest and stress.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stress Echo 2020 - The International Stress Echo Study
NCT03049995
Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity
NCT04828629
Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients
NCT04358952
MYocardial DOmmages Related to COVID-19
NCT04498065
EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
NCT04498091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
echocardiogram 2D
The patient is accelerating against a workload that gradually increases at a constant rate during the exercise, images will be obtained by echocardiography. The patient begins with 25 Watts with increments of 25 Watts every 3 minutes, continuing the exercise until significant electrocardiographic changes occur or the patient starts with symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PCR test negative after COVID-19 illness
* Men or women
* Age ≥18 years and \< 45.
* No history of other cardiovascular or lung disease.
* No cardiovascular risk factors, that is, arterial systemic hypertension, smoking, diabetes, dyslipidemia
* No ongoing or previous cardio or vasoactive treatment
* Able to use the semi-supine exercise bicycle
* Able to give informed consent
Exclusion Criteria
* Tricuspid regurgitation more than mild
* Professional sports activity
* Pregnancy
* Obesity (body mass index \[BMI\], ≥30 kg/m2).
* Inability to provide consent
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Miguel Ayala León
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miguel Ayala León
cardiovascular critical care unit director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Beneficencia Española de Puebla
Puebla City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cardiology-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.